A Delaware jury found that a stent that was formerly sold by Boston Scientific infringed on Johnson & Johnson's Palmaz patent, Boston Scientific said. Monetary damages will be determined at a later hearing, while there likely will be "significant post-verdict motions and hearings, as well as an appeal of the decision," according to a Boston Scientific news release. Boston Scientific no longer markets or sells the stent in question -- the NIR, which was designed and manufactured by Medinol. The company said the jury verdict would have no effect on Boston Scientific's ability to sell its Taxus drug-eluting stent, which competes directly with Johnson & Johnson's Cypher stent. -- by Cinda Becker
Boston Scientific stent found to violate J&J patent
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.